Showing results (2011-2020 of 2,219) with videos related to

Sort By:
Pageof 222
Infection|May 12, 2025
Effective surveillance of acute COVID-19 using a cost- and labor-efficient approach: a paradigm for the longitudinal monitoring of respiratory infections in larger cohortsPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Rheumatology (Oxford, England)|February 7, 2001
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)A J Swaak, H van de Brink, R J Smeenk, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical fieldAnna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
The Lancet. Oncology|February 22, 2015
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 studyLuis Paz-Ares, Jörg Mezger, Tudor E Ciuleanu, et al.
Science Advances|April 14, 2018
HEx: A heterologous expression platform for the discovery of fungal natural productsColin J B Harvey, Mancheng Tang, Ulrich Schlecht, et al.
Rheumatology (Oxford, England)|October 27, 1999
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 21, 2023
Assessment of comorbid symptoms in pediatric autonomic dysfunctionSally E Tarbell, Erin L Olufs, Philip R Fischer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialM Sieber, H Tesch, B Pfistner, et al.
International Journal of Cancer|January 18, 2019
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg casesAnna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, et al.
Pageof 222